Customer Interaction Solutions
Allergan Comments on Pershing Square's Definitive Proxy Solicitation
At the Special Meeting, if called, Allergan stockholders would be asked to remove a majority of the Company's existing directors in connection with Valeant Pharmaceuticals International, Inc.'s unsolicited exchange offer to acquire all outstanding common shares of Allergan for 0.83 shares of Valeant common stock and $72.00 in cash, or subject to ... (more)
Trending on the Topix Network
Press release distribution, EDGAR filing, XBRL, regulatory filings
Curse Inc. and Hi-Rez Studios Announce Integration Between Curse Inc.'s Curse Voice, and Hi-Rez Studios' Poplar Game, SMITE )--Curse Inc. a leading video game media and technology company, and Hi-Rez Studios, creators of the popular online video game, SMITE, announced today the ... )--Delek Logistics Partners, LP today announced that the ... (more)
Mon Jul 07, 2014
Hedge Fund News: Jim Simons, Feroz Dewan & Soros Fund Management
Simonses give $50 million to Cold Spring Harbor lab Long Island hedge-fund investor James Simons and his wife have given $50 million to the Cold Spring Harbor Laboratory to establish a center that uses quantitative tools to understand fundamental biology, including studying disease and illness, the lab said Monday.
Sat Jul 05, 2014
The Motley Fool
This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses
With the SPDR S&P Biotech Index up 45% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector.
Wed Jul 02, 2014
Top 10 Monthly News For June 2014
July 2, 2014 Top 10 Monthly News For June 2014 A happy summer to all of you as we approach July 4th with thoughts of burgers, hot dogs, and beautiful fireworks in the sky.
Tue Jul 01, 2014
Bill Ackman's Pershing Square Settles Litigation With Allergan Inc.
Pershing Square , managed by Bill Ackman , revealed in a new filing with the U.S. Securities and Exchange Commission that it has settled a lawsuit with Allergan Inc. .
Hedge Fund Highlights: John Paulson, Bill Miller & Bridgewater Associates
Paulson's Credit Opportunities fund up 6.6 percent ytd to end-May: source Hedge fund manager John Paulson 's credit opportunities and merger arbitrage funds were up 6.6 percent and 3.3 percent year-to-date through the end of May, respectively, easily surpassing their benchmarks, according to an investor in attendance at Paulson & Co's recent ... (more)
Mon Jun 30, 2014
Hedge Fund Highlights: Bill Ackman, Philip Falcone & Paul Singer
Allergan Poison Pill Won't Be Triggered by Pershing Call Allergan, Inc. agreed with Pershing Square Capital Management LP that a call for a special shareholder meeting to replace part of the drugmaker's board won't trigger a "poison pill" takeover defense.
Investor's Business Daily
Allergan Announces R&D Pipeline Update and U.S. FDA Approval;...
Receives FDA Approval for OZURDEX A 0.7 mg as Treatment Option for Diabetic Macular Edema in Certain Patients-- IRVINE, Calif.-- -- Allergan, Inc. today announced updates on three of the Company's key R&D pipeline programs, including abicipar pegol , bimatoprost sustained-release implant for glaucoma and SEMPRANAa inhalation aerosol .
Thu Jun 26, 2014
The Motley Fool
Biotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Agenus .
Hedge Fund Highlights: Warren Buffett, John Paulson & Bain Capital
Warren Buffett's BNSF and Canadian Pacific Railway gets U.S. deadline to solve grain backlog Warren Buffett 's BNSF Railway Co.
Tue Jun 24, 2014
Allergan Board Unanimously Rejects Valeanta s Unsolicited Takeover Bid
IRVINE, Calif.-After consulting with its independent financial and legal advisors, the board of Allergan, Inc .
#PreMarket Primer: Tuesday, June 24: Pressure On Maliki To Step Down Intensifies
US Secretary of State John Kerry traveled to Baghdad on Monday to pledge the US' "intense" and "sustained" support in Iraq's ongoing crisis.
Mon Jun 23, 2014
The Motley Fool
Monday's Top Biotech Stocks to Watch: Rockwell, AbbVie, Shire, Allergan, and Valeant
Vitamin D deficiency is common in dialysis patients, and can cause elevated parathyroid hormone levels which lead to various bone and joint problems.
Allergan Board of Directors Unanimously Rejects Unsolicited Exchange Offer from Valeant
Accordingly, the Board strongly recommends that Allergan stockholders not tender any Allergan shares to Valeant.
Fri Jun 20, 2014
Shire Soars After Rejecting AbbVie's $46 Billion Inversion Takeover
The potential acquisition is just the latest in a string of 2014 health care merger tries, including Valeant's ongoing pursuit of Allergan , the Abbvie-Shire merger is based on the inversion tax loop hole, in which American countries can avoid US corporate taxes and access overseas profits by reincorporating in the country of their acquisition.
Thu Jun 19, 2014
Valeant Presses Bid for Allergan with Exchange Offer to Stockholders
LAVAL, Quebec- Valeant Pharmaceuticals International , based here, stepped up its bid to acquire Botox-maker Allergan by announcing Wednesday that it is taking its latest proposal directly to Allergan stockholders.
Wed Jun 18, 2014
Allergan Board of Directors to Review Unsolicited Exchange Offer from Valeant
Allergan, Inc. today commented on Valeant Pharmaceuticals International, Inc.'s unsolicited exchange offer to acquire all outstanding common shares of Allergan.
Tue Jun 17, 2014
Investor's Business Daily
Valeant shifts takeover tactics
Allergan has rebuffed multiple earlier offers. Valeant Pharmaceuticals' CEO Michael Pearson said that proxies seeking Allergan shareholder support for the bid will be in the mail soon.
Wellness Center USA, Inc. Featured on Mergermarket
Wellness Center USA, Inc. , a healthcare, medical, and technology solutions company, today announced that its wholly owned subsidiary, Psoria-Shield, was recently featured on Mergermarket, the leading provider of forward-looking M&A intelligence and data to M&A professionals and corporates.